AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
5E10 - A PROSTATE-SPECIFIC SURFACE-REACTIVE MONOCLONAL-ANTIBODY
Authors: ROKHLIN OW WEINER GJ COHEN MB
Citation: Ow. Rokhlin et al., 5E10 - A PROSTATE-SPECIFIC SURFACE-REACTIVE MONOCLONAL-ANTIBODY, Cancer letters, 131(2), 1998, pp. 129-136
ANTI-CD3-BASED BISPECIFIC ANTIBODY DESIGNED FOR THERAPY OF HUMAN B-CELL MALIGNANCY CAN INDUCE T-CELL ACTIVATION BY ANTIGEN-DEPENDENT AND ANTIGEN-INDEPENDENT MECHANISMS
Authors: LINK BK KOSTELNY SA COLE MS FUSSELMAN WP TSO JY WEINER GJ
Citation: Bk. Link et al., ANTI-CD3-BASED BISPECIFIC ANTIBODY DESIGNED FOR THERAPY OF HUMAN B-CELL MALIGNANCY CAN INDUCE T-CELL ACTIVATION BY ANTIGEN-DEPENDENT AND ANTIGEN-INDEPENDENT MECHANISMS, International journal of cancer, 77(2), 1998, pp. 251-256
IMMUNOSTIMULATORY CPG OLIGODEOXYNUCLEOTIDES ENHANCE THE IMMUNE-RESPONSE TO VACCINE STRATEGIES INVOLVING GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
Authors: LIU HM NEWBROUGH SE BHATIA SK DAHLE CE KRIEG AM WEINER GJ
Citation: Hm. Liu et al., IMMUNOSTIMULATORY CPG OLIGODEOXYNUCLEOTIDES ENHANCE THE IMMUNE-RESPONSE TO VACCINE STRATEGIES INVOLVING GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, Blood, 92(10), 1998, pp. 3730-3736
RANDOMIZED STUDY OF PROPHYLACTIC PLATELET TRANSFUSION THRESHOLD DURING INDUCTION THERAPY FOR ADULT ACUTE-LEUKEMIA - 10,000 MU-L VERSUS 20,000/MU-L/
Authors: HECKMAN KD WEINER GJ DAVIS CS STRAUSS RG JONES MP BURNS CP
Citation: Kd. Heckman et al., RANDOMIZED STUDY OF PROPHYLACTIC PLATELET TRANSFUSION THRESHOLD DURING INDUCTION THERAPY FOR ADULT ACUTE-LEUKEMIA - 10,000 MU-L VERSUS 20,000/MU-L/, Journal of clinical oncology, 15(3), 1997, pp. 1143-1149
T-CELL ACTIVATION-INDUCED BY ANTI-CD3-X-ANTI-B-CELL LYMPHOMA MONOCLONAL-ANTIBODY IS ENHANCED BY PRETREATMENT OF LYMPHOMA-CELLS WITH SOLUBLECD40 LIGAND
Authors: WOOLDRIDGE JE DAHLE CE WEINER GJ
Citation: Je. Wooldridge et al., T-CELL ACTIVATION-INDUCED BY ANTI-CD3-X-ANTI-B-CELL LYMPHOMA MONOCLONAL-ANTIBODY IS ENHANCED BY PRETREATMENT OF LYMPHOMA-CELLS WITH SOLUBLECD40 LIGAND, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 174-179
IMMUNOSTIMULATORY OLIGODEOXYNUCLEOTIDES CONTAINING THE CPG MOTIF ARE EFFECTIVE AS IMMUNE ADJUVANTS IN TUMOR-ANTIGEN IMMUNIZATION
Authors: WEINER GJ LIU HM WOOLDRIDGE JE DAHLE CE KRIEG AM
Citation: Gj. Weiner et al., IMMUNOSTIMULATORY OLIGODEOXYNUCLEOTIDES CONTAINING THE CPG MOTIF ARE EFFECTIVE AS IMMUNE ADJUVANTS IN TUMOR-ANTIGEN IMMUNIZATION, Proceedings of the National Academy of Sciences of the United Statesof America, 94(20), 1997, pp. 10833-10837
IMMUNOSTIMULATORY OLIGODEOXYNUCLEOTIDES CONTAINING CPG MOTIFS ENHANCETHE EFFICACY OF MONOCLONAL-ANTIBODY THERAPY OF LYMPHOMA
Authors: WOOLDRIDGE JE BALLAS Z KRIEG AM WEINER GJ
Citation: Je. Wooldridge et al., IMMUNOSTIMULATORY OLIGODEOXYNUCLEOTIDES CONTAINING CPG MOTIFS ENHANCETHE EFFICACY OF MONOCLONAL-ANTIBODY THERAPY OF LYMPHOMA, Blood, 89(8), 1997, pp. 2994-2998
IMMUNOSTIMULATORY OLIGODEOXYNUCLEOTIDES CONTAINING CPG MOTIFS ENHANCEANTIBODY-DEPENDENT CYTOTOXICITY IN-VITRO AND IMPROVE THE EFFICACY OF MONOCLONAL-ANTIBODY THERAPY IN-VIVO
Authors: WOOLDRIDGE JE BALLAS Z KRIEG AM WEINER GJ
Citation: Je. Wooldridge et al., IMMUNOSTIMULATORY OLIGODEOXYNUCLEOTIDES CONTAINING CPG MOTIFS ENHANCEANTIBODY-DEPENDENT CYTOTOXICITY IN-VITRO AND IMPROVE THE EFFICACY OF MONOCLONAL-ANTIBODY THERAPY IN-VIVO, Journal of investigative medicine, 44(7), 1996, pp. 375-375
EXPRESSION OF BOTH B7-1 AND CD28 CONTRIBUTES TO THE IL-2 RESPONSIVENESS OF CTLL-2 CELLS
Authors: BELANI R WEINER GJ
Citation: R. Belani et Gj. Weiner, EXPRESSION OF BOTH B7-1 AND CD28 CONTRIBUTES TO THE IL-2 RESPONSIVENESS OF CTLL-2 CELLS, Immunology, 87(2), 1996, pp. 271-274
THE KINETICS AND DYNAMICS OF RESPONSES TO PLACEBO
Authors: WEINER M WEINER GJ
Citation: M. Weiner et Gj. Weiner, THE KINETICS AND DYNAMICS OF RESPONSES TO PLACEBO, Clinical pharmacology and therapeutics, 60(3), 1996, pp. 247-254
IMMUNOSTIMULATORY CPG OLIGODEOXYNUCLEOTIDE IS EFFECTIVE AS AN ADJUVANT IN INDUCING PRODUCTION OF ANTIIDIOTYPE ANTIBODY AND IS SYNERGISTIC WITH GMCSF
Authors: WEINER GJ WOODRIDGE JE LIU H DAHLE CE KRIEG AM
Citation: Gj. Weiner et al., IMMUNOSTIMULATORY CPG OLIGODEOXYNUCLEOTIDE IS EFFECTIVE AS AN ADJUVANT IN INDUCING PRODUCTION OF ANTIIDIOTYPE ANTIBODY AND IS SYNERGISTIC WITH GMCSF, Blood, 88(10), 1996, pp. 348-348
ANTI-CD3 X ANTI-1D10 BISPECIFIC ANTIBODY RETARGETS AND ENHANCES THE CYTOTOXICITY OF CYTOKINE-INDUCED KILLER-CELLS
Authors: WANG ZH LU PH WEINER GJ TSO J NEGRIN RS
Citation: Zh. Wang et al., ANTI-CD3 X ANTI-1D10 BISPECIFIC ANTIBODY RETARGETS AND ENHANCES THE CYTOTOXICITY OF CYTOKINE-INDUCED KILLER-CELLS, Blood, 88(10), 1996, pp. 1253-1253
HLA CLASS-II AS POTENTIAL TARGET ANTIGEN ON MALIGNANT B-CELLS FOR THERAPY WITH BISPECIFIC ANTIBODIES IN COMBINATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR
Authors: ELASSER D VALERIUS T REPP R WEINER GJ DEO Y KALDEN JR VANDEWINKEL JGJ STEVENSON GT GLENNIE MJ GRAMATZKI M
Citation: D. Elasser et al., HLA CLASS-II AS POTENTIAL TARGET ANTIGEN ON MALIGNANT B-CELLS FOR THERAPY WITH BISPECIFIC ANTIBODIES IN COMBINATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR, Blood, 87(9), 1996, pp. 3803-3812
BISPECIFIC MONOCLONAL-ANTIBODY THERAPY OF B-CELL MALIGNANCY
Authors: WEINER GJ DEGAST GC
Citation: Gj. Weiner et Gc. Degast, BISPECIFIC MONOCLONAL-ANTIBODY THERAPY OF B-CELL MALIGNANCY, Leukemia & lymphoma, 16(3-4), 1995, pp. 199-207
BONE-MARROW MORPHOLOGY DURING INDUCTION-PHASE OF THERAPY FOR ACUTE MYELOID-LEUKEMIA (AML)
Authors: DICK FR BURNS CP WEINER GJ HECKMAN KD
Citation: Fr. Dick et al., BONE-MARROW MORPHOLOGY DURING INDUCTION-PHASE OF THERAPY FOR ACUTE MYELOID-LEUKEMIA (AML), Hematologic pathology, 9(2), 1995, pp. 95-106
PRODUCTION AND INITIAL EVALUATION OF A HUMANIZED BSF(AB')(2) ANTI-CD3-BASED BISPECIFIC MONOCLONAL-ANTIBODY DESIGNED FOR THERAPY OF HUMAN B-CELL MALIGNANCIES
Authors: LINK BK MOES R FUSSELMAN WP KOSTELNY SA COLE MS TSO JY WEINER GJ
Citation: Bk. Link et al., PRODUCTION AND INITIAL EVALUATION OF A HUMANIZED BSF(AB')(2) ANTI-CD3-BASED BISPECIFIC MONOCLONAL-ANTIBODY DESIGNED FOR THERAPY OF HUMAN B-CELL MALIGNANCIES, Blood, 86(10), 1995, pp. 1264-1264
ANTIIDIOTYPE ANTIBODY AND CD40 LIGAND EACH INDUCE EXPRESSION OF B7 MOLECULES BY MALIGNANT B-CELLS AND ENHANCE THEIR ABILITY TO ACTIVATE T-CELLS
Authors: BELANI R WOOLDRIDGE JE ZIMMERMANN MS HSING Y THOMAS EK WEINER GJ
Citation: R. Belani et al., ANTIIDIOTYPE ANTIBODY AND CD40 LIGAND EACH INDUCE EXPRESSION OF B7 MOLECULES BY MALIGNANT B-CELLS AND ENHANCE THEIR ABILITY TO ACTIVATE T-CELLS, Blood, 86(10), 1995, pp. 1269-1269
HLA CLASS-II AS POTENTIAL TARGET ANTIGEN ON MALIGNANT B-CELLS FOR THERAPY WITH BISPECIFIC ANTIBODIES IN COMBINATION WITH G-CSF
Authors: VALERIUS T REPP R ELSASSER D WURFLEIN D WEINER GJ DEO Y KALDEN JR VANDEWINKEL JJG GLENNIE MJ GRAMATZKI M
Citation: T. Valerius et al., HLA CLASS-II AS POTENTIAL TARGET ANTIGEN ON MALIGNANT B-CELLS FOR THERAPY WITH BISPECIFIC ANTIBODIES IN COMBINATION WITH G-CSF, Blood, 86(10), 1995, pp. 2132-2132
EXPRESSION OF BOTH B7-1 AND CD28 CONTRIBUTES TO THE IL-2 RESPONSIVENESS OF CTLL-2 CELLS
Authors: BELANI R WEINER GJ
Citation: R. Belani et Gj. Weiner, EXPRESSION OF BOTH B7-1 AND CD28 CONTRIBUTES TO THE IL-2 RESPONSIVENESS OF CTLL-2 CELLS, Blood, 86(10), 1995, pp. 2838-2838
SELECT UNMETHYLATED CPG OLIGODEOXYNUCLEOTIDES IMPROVE ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY IN-VITRO OF BOTH MURINE AND HUMAN B-CELL LYMPHOMAS
Authors: WOOLDRIDGE JE HSING Y BALLAS Z KRIEG AM WEINER GJ
Citation: Je. Wooldridge et al., SELECT UNMETHYLATED CPG OLIGODEOXYNUCLEOTIDES IMPROVE ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY IN-VITRO OF BOTH MURINE AND HUMAN B-CELL LYMPHOMAS, Blood, 86(10), 1995, pp. 2877-2877
THE SAFETY AND PHARMACOKINETICS IN ADULT SUBJECTS OF AN INTRAVENOUSLYADMINISTERED TC-99M-LABELED 17 AMINO-ACID PEPTIDE (CYT-379)
Authors: BENHAIM S KAHN D WEINER GJ MADSEN MT WAXMAN AD WILLIAMS CM CLARKEPEARSON DL COLEMAN RE MAGUIRE RT
Citation: S. Benhaim et al., THE SAFETY AND PHARMACOKINETICS IN ADULT SUBJECTS OF AN INTRAVENOUSLYADMINISTERED TC-99M-LABELED 17 AMINO-ACID PEPTIDE (CYT-379), Nuclear medicine and biology, 21(2), 1994, pp. 131-142
RADIOLABELED ANTIBODY IMAGING OF PATIENTS WITH POTENTIALLY RESECTABLECOLORECTAL ADENOCARCINOMA
Authors: WEINER GJ KAHN D JOCHIMSEN PR BEVERING CG KISKER MA
Citation: Gj. Weiner et al., RADIOLABELED ANTIBODY IMAGING OF PATIENTS WITH POTENTIALLY RESECTABLECOLORECTAL ADENOCARCINOMA, Cancer investigation, 12(2), 1994, pp. 111-120
RADIOIMMUNOSCINTIGRAPHY WITH (111)INDIUM LABELED CYT-356 FOR THE DETECTION OF OCCULT PROSTATE-CANCER RECURRENCE
Authors: KAHN D WILLIAMS RD SELDIN DW LIBERTINO JA HIRSCHHORN M DREICER R WEINER GJ BUSHNELL D GULFO J
Citation: D. Kahn et al., RADIOIMMUNOSCINTIGRAPHY WITH (111)INDIUM LABELED CYT-356 FOR THE DETECTION OF OCCULT PROSTATE-CANCER RECURRENCE, The Journal of urology, 152(5), 1994, pp. 1490-1495
THE ROLE OF T-CELL ACTIVATION IN ANTI-CD3 X ANTITUMOR BISPECIFIC ANTIBODY THERAPY
Authors: WEINER GJ KOSTELNY SA HILLSTROM JR COLE MS LINK BK WANG SL TSO JY
Citation: Gj. Weiner et al., THE ROLE OF T-CELL ACTIVATION IN ANTI-CD3 X ANTITUMOR BISPECIFIC ANTIBODY THERAPY, The Journal of immunology, 152(5), 1994, pp. 2385-2392
IMMUNOSCINTIGRAPHY WITH IN-111-SATUMOMAB PENDETIDE IN PATIENTS WITH COLORECTAL ADENOCARCINOMA - PERFORMANCE AND IMPACT ON CLINICAL MANAGEMENT
Authors: CORMAN ML GALANDIUK S BLOCK GE PRAGER ED WEINER GJ KAHN D ABDELNABI H MITCHELL EP PASCUCCI VL MAROLI AN MAGUIRE RT
Citation: Ml. Corman et al., IMMUNOSCINTIGRAPHY WITH IN-111-SATUMOMAB PENDETIDE IN PATIENTS WITH COLORECTAL ADENOCARCINOMA - PERFORMANCE AND IMPACT ON CLINICAL MANAGEMENT, Diseases of the colon & rectum, 37(2), 1994, pp. 129-137
Risultati: 1-25 | 26-32